NORTH
CHICAGO, Ill., Nov. 25,
2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will
participate in Citi's 2024 Global Healthcare Conference on
Tuesday, December 3, 2024.
Scott T. Reents, executive vice
president, chief financial officer, Jeffrey
R. Stewart, executive vice president, chief commercial
officer and Roopal Thakkar, M.D.,
executive vice president, Research & Development and chief
scientific officer, will present at 9:15
a.m. Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
LinkedIn, Facebook, Instagram, X (formerly Twitter), and
YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-citis-2024-global-healthcare-conference-302314669.html
SOURCE AbbVie
